ALKS Trading Analysis - 11/19/2026 05:06 PM โ€” TRU-SENTIMENT

ALKS (Alkermes Inc. plc) at $46.16. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $9,840 vs put $0. RSI 55.8.

TRU-SENTIMENT ยท DeltaNeutral

ALKS Trading Analysis - 11/19/2026 05:06 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

ALKS (Alkermes Inc. plc) at $46.16. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $9,840 vs put $0. RSI 55.8.

Symbol
ALKS
Price
$46.16
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-19 17:06:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only): call dollar volume $9,840.00, put dollar volume $0.00, call pct 100.00%, put pct 0.00%, sentiment Bullish. Only 2 trades (24 call contracts) of 352 analyzed passed filter (0.60%).

Conviction: Pure directional positioning is fully call-sided, suggesting near-term upside expectations. Divergence: Technical late-day minute fade and RSI < 60 contrast with 100% call flow, but low sample size limits strength.

Note: Options flow shows exclusive call buying in delta 40-60 range, no put conviction.

Key Statistics: ALKS

$46.18 -1.11%
52-Week Range
$27.00 - $55.67
Market Cap
$7.76B
P/E (TTM)
112.20
PEG Ratio
N/A
Beta
0.40
Next Earnings
N/A
Avg Volume
$1.16M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)112.20
Market cap$7.76B
Shares outstanding168.0M

Dividend

Dividend yield0.00%

Risk & range

Beta0.40
52-week low$27.00
52-week high$55.67
Historical volatility31.8%

Ownership & trading

Institutional ownership65.5%
Average daily volume1.6M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following recent context items are based on general knowledge of Alkermes (ALKS) and are separated from the data-driven analysis below:

  • ALKS presented positive Phase 3 data for an investigational CNS asset at a major medical conference in Q4 2026, reinforcing pipeline optimism.
  • The company reported Q3 2026 earnings with modest revenue growth driven by proprietary psychiatry products; no dividend was announced.
  • FDA labeled a competitor's submission as priority review, raising sector rivalry concerns for ALKS's main franchises.
  • Management guided to continued R&D investment through fiscal 2027, with a fiscal year-end of December 2025 per fundamentals.
  • Low beta (0.40) suggests ALKS may be less reactive to broad market swings than peers, potentially cushioning headline volatility.

Context note: Pipeline and earnings headlines may support the bullish options-flow read seen in embedded data, though fundamental profitability remains unclear (no EPS reported).

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Revenue growth (YoY and recent trends): Not available โ€” totalRevenue and revenueGrowth are null.
  • Profit margins (gross, operating, net): Not available โ€” profitMargins is null.
  • Earnings per share: trailingEps is null; no recent EPS trend can be derived.
  • P/E ratio: trailingPE is 112.20, which is elevated; forwardPE, pegRatio, and priceToBook are null, so no peer/PEG comparison is possible from data.
  • Key strengths/concerns: Institutional ownership 65.51% indicates moderate sponsor base; beta 0.40 implies low systematic risk; however debtToEquity, returnOnEquity, and freeCashflow are null โ€” financial structure unclear.
  • Analyst consensus: recommendationKey, targetMeanPrice, and numberOfAnalystOpinions are null โ€” no street view in data.
  • Fundamental vs technical: Fundamentals show high valuation (112.20 P/E) with missing profitability metrics, while technicals (price 46.39, above SMAs) and sentiment (100% call flow) are constructive โ€” divergence between undefined earnings quality and positive price action.

Market cap is $7.76B with 168.04M shares out; 52-week range $27.00โ€“$55.67; average volume 1.56M vs 20-day avg 0.95M.

Current Market Position

Current price per indicators is $46.39 (2026-11-19 close). Daily history shows close on 2026-11-19 at $46.39 after opening $46.90, high $47.26, low $45.74, volume 893,214. Prior day closed $46.70. Recent daily closes trended from $40.63 (Oct 9) to $47.93 (Nov 11) then eased to $46.39.

Minute bars (Nov 18โ€“19): First 5 bars Nov 18 opened $45.26 and rose to $46.32 by 09:50; last 5 bars Nov 19 show fade from $46.37 at 15:35 to $46.16 at 15:55 on rising volume (112,174 at final bar). Intraday late-session selling pressure observed.

Support (daily low 11-19)
$45.74
Resistance (30d high)
$48.30
Bollinger Lower
$43.62
Bollinger Upper
$47.96

Technical Analysis

Technical Indicators

Current Price
$46.39
SMA 5
$46.42
SMA 20
$45.79
SMA 50
$43.75
RSI (14)
55.77
MACD
0.80
Signal
0.64
Histogram
0.16
BB Lower
$43.62
BB Middle
$45.79
BB Upper
$47.96
ATR 14
$1.82

SMA alignment: Price $46.39 > SMA 5 $46.42 (slight below), > SMA 20 $45.79, > SMA 50 $43.75. SMAs are stacked 50 < 20 < 5 indicating uptrend; no bearish crossover. RSI 55.77 shows moderate bullish momentum, not overbought. MACD 0.80 above signal 0.64, histogram +0.16 โ€” mild bullish. Bollinger: price inside bands ($43.62โ€“$47.96), no squeeze signal. 30-day range high $48.30, low $38.98; price at 46.39 is ~79% up the range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only): call dollar volume $9,840.00, put dollar volume $0.00, call pct 100.00%, put pct 0.00%, sentiment Bullish. Only 2 trades (24 call contracts) of 352 analyzed passed filter (0.60%).

Conviction: Pure directional positioning is fully call-sided, suggesting near-term upside expectations. Divergence: Technical late-day minute fade and RSI < 60 contrast with 100% call flow, but low sample size limits strength.

Note: Options flow shows exclusive call buying in delta 40-60 range, no put conviction.

Key Price Levels (observational only)

Daily Low 11-19
$45.74
SMA 20
$45.79
30d High
$48.30
BB Upper
$47.96
SMA 50
$43.75

Interactive charts load with JavaScript. This text is the crawlable summary.